$PATH

Why Is UiPath Stock Falling on Monday? - UiPath (NYSE:PATH)

UiPath (NYSE:PATH) stock fell on Monday after DA Davidson downgraded it to Underperform with a $10 price target. Several other brokerages also cut their price forecasts. The stock is trading 17.3% below its 20-day SMA and 17.1% below its 50-day SMA. UiPath shares were down 1.89% at $12.23 at the time of publication.

Original reporting
Published Sep 28, 2026, 3:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$PATH
Bearish
medium confidence
Mentioned
$PATH
Relevance
7/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

The downgrade is the primary catalyst for the stock's 1.9% decline, suggesting short‑term downside risk.

02

Market read

The news directly affects UiPath shareholders and may influence sentiment toward the broader automation sector.

03

What to watch

Strong growth in high‑ARR customers and a clear path to >30% operating margin could support a rebound.

Relevance 7/10Novelty 7/10Timing: today

Background

UiPath reported a series of analyst target cuts after its Investor Day, with the latest downgrade from DA Davidson.

Company-level read

Ticker impact

$PATHBearishMedium confidence
Context

DA Davidson downgraded UiPath to Underperform and set a $10 price target, triggering a 1.9% drop in the stock.

Expected impact

downward pressure as investors price in the lower target and underperform rating

Evidence & confidence

Multiple brokerages also cut targets this week, reinforcing the negative outlook and likely prompting short‑term sell orders.

Market effects

RPA and automation software sector may see broader weakness as analysts reassess growth prospects.

US tech equities could face modest pullback in the near term.

Limited to investors with exposure to UiPath and comparable automation firms.

Counterpoint

The downgrade may overstate short‑term concerns given UiPath's expanding AI‑driven product suite.

Key entities

  • UiPath Inc.

    Robotic process automation software provider listed on NYSE under PATH.

  • DA Davidson

    Equity research firm that issued the Underperform rating and $10 price target.

Related articles

$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.

$PATHHigh

UiPath (PATH) Stock: Jump as Gartner Recognizes IDP Leadership

UiPath (PATH) stock rose 7.53% to $14.78 after Gartner named it a Leader in Intelligent Document Processing for the second year. The recognition highlights UiPath's role in enterprise automation and document management, with its IXP platform converting complex documents into structured data for workflows.

$PATHMedAI 8/10

UiPath Stock Rises 2.2%—Why Its 89% AI Survey Result Isn’t Revenue Yet

UiPath (PATH) shares rose 2.21% to $13.87 on Thursday, though still down 23.9% from pre-earnings levels. A company-sponsored survey showed 89% of respondents with embedded orchestration met ROI expectations, but this doesn't guarantee revenue growth. Q2 revenue increased 13% to $410M, with ARR up 12% to $1.938B. Management expects Q3 ARR of $1.992B-$1.997B. Investors await evidence of monetization at Investor Day on September 22.

$PATHHigh

Citi Just Upgraded UiPath Stock. Here's Why.

Citi's Yitchuin Wong upgraded UiPath (PATH) to 'Buy' with a $23 price target, citing its AI orchestration role and 60% upside potential. PATH stock has fallen 25% year-to-date after missing Q3 revenue estimates, but Wong sees long-term value in its AI integration and raised full-year revenue outlook to $1.789B, exceeding Zacks' consensus.